Jiangang Liu
5PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 27, 2024
Best Overall Response-Associated Signature to Doxorubicin in Soft Tissue Sarcomas: A Transcriptomic Analysis from ANNOUNCE.Jiangang Liu, David S Moura, Robin L Jones
|Oct 31, 2023
Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients.Sara M Tolaney, Shom Goel, Jorge Nadal
|Jul 05, 2023
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.Alyssa C Flint, Dana K Mitchell, Steven P Angus
|Feb 04, 2021
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo
|Oct 17, 2019
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2- Breast Cancer.Sara A Hurvitz, Miguel Martin, Michael F Press
Pageof 1
Frequent Collaborators
2 joint publications
Amit Aggarwal
1 joint publications
Miguel Martin
1 joint publications
Susana Barriga
1 joint publications
Xiaoyong Fu
1 joint publications
Tao Wang
1 joint publications
Susan G Hilsenbeck
1 joint publications
Matteo Benelli
1 joint publications
Luca Malorni
1 joint publications
Rinath Jeselsohn
1 joint publications
Rachel Schiff
